Article Text

PDF
Validation of COBAS Taqman CT for the detection of Chlamydia trachomatis in vulvo-vaginal swabs
  1. S Skidmore,
  2. M Kaye,
  3. D Bayliss,
  4. S Devendra
  1. Departments of Microbiology and Genitourinary Medicine, Shrewsbury and Telford Hospital NHS Trust, Telford, UK
  1. Dr Sue Skidmore, Department of Microbiology, Princess Royal Hospital, Telford TF1 1TF, UK; sue.skidmore{at}sath.nhs.uk

Abstract

Background: Vulvo-vaginal swabs (VVSs) are not validated for use by the manufacturers of two widely used nucleic acid amplification tests (NAAT) for the detection of Chlamydia trachomatis. However, there is evidence that this type of swab is suitable for diagnosis.

Objective: To validate the Cobas Taqman CT assay for the detection of C trachomatis in VVS.

Method: Women aged 18–24 years attending a genitourinary medicine clinic were invited to take part in the study. Participants provided a self-taken VVS and the results obtained with these samples were compared with those obtained with an endocervical swab collected by a healthcare worker. A total of 267 women took part.

Results: 255/267 (96%; 95% CI 92 to 98%) sets of samples gave concordant results. 12/267 (4.5%) VVSs were invalid/inhibitory and so no result was available for these samples. This compared with 2/267 (0.7%) for endocervical swabs.

Conclusion: VVS are suitable samples for detecting C trachomatis.

Statistics from Altmetric.com

Footnotes

  • Contributors: SS and MK wrote the protocol and obtained ethics approval. DB and SD recruited patients. All contributed to the preparation of the manuscript.

  • Competing interests: None.

  • Ethics approval: Ethics approval was obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles